For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Immunovant Inc (NASDAQ: IMVT) closed at $16.73 up 2.39% from its previous closing price of $16.34. In other words, the price has increased by $2.39 from its previous closing price. On the day, 1.29 million shares were traded. IMVT stock price reached its highest trading level at $16.85 during the session, while it also had its lowest trading level at $16.44.
Ratios:
For a deeper understanding of Immunovant Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.32 and its Current Ratio is at 12.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 03, 2025, Jefferies started tracking the stock assigning a Hold rating and target price of $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 23 ’25 when Stout Jay S sold 2,805 shares for $18.15 per share. The transaction valued at 50,911 led to the insider holds 204,919 shares of the business.
Geffner Michael sold 2,385 shares of IMVT for $43,288 on Jul 23 ’25. The Chief Medical Officer now owns 221,825 shares after completing the transaction at $18.15 per share. On Jul 09 ’25, another insider, Geffner Michael, who serves as the Chief Medical Officer of the company, sold 1,160 shares for $17.24 each. As a result, the insider received 19,998 and left with 224,210 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 2916320768 and an Enterprise Value of 2317408768.
Stock Price History:
The Beta on a monthly basis for IMVT is 0.56, which has changed by -0.4516552 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $32.10, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is 6.03%, while the 200-Day Moving Average is calculated to be -6.33%.
Shares Statistics:
For the past three months, IMVT has traded an average of 1.47M shares per day and 1816890 over the past ten days. A total of 171.07M shares are outstanding, with a floating share count of 70.59M. Insiders hold about 59.50% of the company’s shares, while institutions hold 55.30% stake in the company. Shares short for IMVT as of 1757894400 were 16147300 with a Short Ratio of 10.96, compared to 1755216000 on 16067954. Therefore, it implies a Short% of Shares Outstanding of 16147300 and a Short% of Float of 27.01.
Earnings Estimates
As of right now, 13.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.73, with high estimates of -$0.6 and low estimates of -$0.87.
Analysts are recommending an EPS of between -$2.33 and -$3.32 for the fiscal current year, implying an average EPS of -$2.91. EPS for the following year is -$3.03, with 10.0 analysts recommending between -$1.96 and -$3.98.
